期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

多发性骨髓瘤继发第二肿瘤四例并文献复习 被引量：3

原文传递
导出
摘要 目的报道4例多发性骨髓瘤(MM)继发第二肿瘤的病例,结合文献复习,提高对MM继发第二肿瘤的认识。方法回顾性分析4例MM继发第二肿瘤患者的临床特点、治疗经过及预后,就相关文献进行复习。结果 MM继发第二肿瘤发病率低,实体肿瘤及血液系统肿瘤均可发生。结论 MM继发第二肿瘤发病机制不明确,有待于进一步研究。
作者 孟翠玉 傅晋翔 陈萍
机构地区 苏州大学附属第二医院血液科
出处 《中华临床医师杂志（电子版）》 CAS 2014年第3期185-188,共4页 Chinese Journal of Clinicians(Electronic Edition)
基金 国家自然科学基金(81071934 81272631)
关键词 多发性骨髓瘤 第二肿瘤 免疫调节剂
分类号 R733.3 [医药卫生—肿瘤]
  • 相关文献

参考文献13

  • 1Young D.NCI reports on risks of new cancers in survivors[J].Am J Health Syst Pharm,2007,64(5):454-456.
  • 2The Finnish Leukaemia Group.Acute leukaemia and other secondary neoplasms in patients treated with conventional chemotherapy for multiple myeloma:a Finnish Leukaemia Group study[J].Eur J Haematol,2000,65(2):123-127.
  • 3Hasskarl J,Ihorst G,De Pasquale D,et al.Association of multiple myeloma with different neoplasms:systematic analysis in consecutive patients with myeloma[J].Leuk Lymphoma,2011,52(2):247-259.
  • 4Thomas A,Mailankody S,Korde N,et al.Second malignancies after multiple myeloma:from 1960s to 2010s[J].Blood,2012,119(12):2731-2737.
  • 5Dimopoulos MA,Richardson PG,Brandenburg N,et al.A review of second primary malignancy in patients with relapsed or refractory multiple myeloma treated with lenalidomide[J].Blood,2012,119(12):2764-2767.
  • 6Rossi AC,Mark TM,Jayabalan D,et al.Incidence of second primary malignancies(SPM)after 6-years follow-up of continuous lenalidomide in first-line treatment of multiple myeloma(MM)[abstract][J].J Clin Oncol,2011,29:Abstract 8008.
  • 7Usmani SZ,Sexton R,Horring A,et al.Second malignancies in total therapy 2 and 3 for newly diagnosed multiple myeloma:influence of thalidomide and lenalidomide during maintenance[J].Blood,2012,120(8):1597-1600.
  • 8Mailankody S,Pfeiffer RM,Kristinsson SY,et al.Risk of acute myeloid leukemia and myelodysplastic syndromes following multiple myeloma and its precursor disease(MGUS)[J].Blood,2011,118(15):4086-4092.
  • 9Dong C,Hemminki K.Second primary neoplasms among 53159haematolymphoproliferative malignancy patients in Sweden,1958-1996:a search for common mechanisms[J].Br J Cancer,2001,85(7):997-1005.
  • 10Landgren O,Ma W,Kyle RA,et al.Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma[J].Leukemia,2012,26(4):844-845.

同被引文献20

  • 1杨光忠,陈文明.多发性骨髓瘤继发膀胱癌一例[J].中国全科医学,2009,12(8):699-700. 被引量：2
  • 2王婷玉,黄晓鸥,徐才刚,陈心传,王晖.多发性骨髓瘤继发急性粒单核细胞白血病1例报告[J].四川大学学报（医学版）,2007,38(2):347-349. 被引量：4
  • 3Travis LB,Fossa SD,Schonfeld SJ,et al.Second cancers among 40,576 testicular cancer patients:focus on longterm survivors[J].J Natl Cancer Inst,2005,97(18):1354-1365.
  • 4Mauch PM,Kalish LA,Marcus KC,et al.Long-term survival in Hodgkinr s disease relative impact of mortality,second tumors,infection,and cardiovascular disease[J].Cancer J Sci Am,2006,1(1):33-42.
  • 5Curtis RE,Ron E,Ries LAG,et al.New Malignancies A-mong Cancer Survivors:SEER Cancer Registries,1973-2000[M].Bethesda,MD:National Institutes of Health,2006:397-441.
  • 6Thomas A,Mailankody S? Korde N,et al.Second malignancies after multiple myeloma:from 1960s to 2010s[J].Blood,2012,119(12):2731-2737.
  • 7Bergsagel DE,Bailey AJ,Langley GR,et al.The chemotherapy on plasma-cell myeloma and the incidence of acute leukemia[J].N Engl J Med,1979,301(14);743-748.
  • 8Greene MH,Harris EL,Gershenson DM?et al.Melphalan May be a more potent leukemogen than cyclophosphamide[J],Ann Intern Med,1986,105(3):360-367.
  • 9Pedersen-Bjergaard J,Ersboll J,Sorensen HM,et al.Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas.Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents[J].Ann Intern Med,1985,103(2):195-200.
  • 10Usmani SZ5Sawyer J,Rosenthal A,et al.Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma[J].Blood,2013,121(23):4753-4757.

引证文献3

二级引证文献2

中华临床医师杂志（电子版）
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部